We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
THERAPEUTIC GOODS ACT 1989
I, SHELLEY TANG, Acting Head, Office of Devices, Blood and Tissues, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of subsection 42DK(1) of the Therapeutic Goods Act 1989 give notice that the restricted representations described in paragraph (a) below, have been approved for use in advertisements directed to consumers, for the goods listed in paragraph (b) provided the conditions identified in paragraph (c) are met:
- Representations to the effect that the goods described in paragraph (b) are used:
- "in the treatment of moderate to profound hearing loss"
- Cochlear Implant System and the Baha Bone Conduction System
- The advertisement in which the representation is made must comply with the Therapeutic Goods Advertising Code as defined in subsection 3(1) of the Therapeutic Goods Act 1989, and must advise consumers to seek advice from their medical practitioner.
Dated this 29th day of July 2008